Giroux, L M <br/><br/>
Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages.  [electronic resource] 

 -  Biochimica et biophysica acta  Jan 1993 
 - 335-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3002 
<br/><br/><label>Standard No.: </label>10.1016/0005-2760(93)90145-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Interactions<br/>Humans<br/>Hydroxymethylglutaryl CoA Reductases--pharmacology<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors<br/>Lipoproteins, LDL--metabolism<br/>Lovastatin--analogs & derivatives<br/>Macrophage Activation<br/>Macrophages--drug effects<br/>Mevalonic Acid--pharmacology<br/>Monocytes--drug effects<br/>Oxidation-Reduction--drug effects<br/>Simvastatin<br/>Superoxides--metabolism<br/>Tetradecanoylphorbol Acetate--pharmacology